Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In IRadimed Corporation (IRMD) To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at IRadimed Corporation (“IRadimed” or the “Company”) (NASDAQ: IRMD).
On September 3, 2014, the Company announced that it had received a warning letter from the U.S. Food and Drug Administration relating to an April 2014 inspection of the Company’s facility. The warning letter also requests that IRadimed immediately cease certain activities that result in misbranding and adulteration of certain of the Company’s products.
Following this news, the price of IRadimed stock declined by $3.25 per share, or over 31%, to close on September 3, 2014 at $7.15 per share.
If you invested in IRadimed stock prior to September 3, 2014 and would like to discuss your legal rights, you can contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to firstname.lastname@example.org. Faruqi & Faruqi, LLP also encourages anyone with information regarding IRadimed’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.